Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Shepard

Showing results (251-260 of 310) with videos related to

Pageof 31
Sort By:
Journal of the American Chemical Society|December 29, 2020
Active-Site Controlled, Jahn-Teller Enabled Regioselectivity in Reductive S-C Bond Cleavage of <i>S</i>-Adenosylmethionine in Radical SAM EnzymesStella Impano, Hao Yang, Richard J Jodts, et al.
The Journal of Biological Chemistry|August 5, 1991
p185HER2 signal transduction in breast cancer cellsG K Scott, J M Dodson, P A Montgomery, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 1992
Humanization of an anti-p185HER2 antibody for human cancer therapyP Carter, L Presta, C M Gorman, et al.
Angewandte Chemie (International Ed. in English)|March 23, 2022
[FeFe]-Hydrogenase: Defined Lysate-Free Maturation Reveals a Key Role for Lipoyl-H-Protein in DTMA Ligand BiosynthesisAdrien Pagnier, Batuhan Balci, Eric M Shepard, et al.
Journal of Medicinal Chemistry|April 14, 1995
The C-32 triacetyl-L-rhamnose derivative of ascomycin: a potent, orally active macrolactone immunosuppressantK Koch, M F Newborg, D C Hanson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2006
The human specific CCR1 antagonist CP-481,715 inhibits cell infiltration and inflammatory responses in human CCR1 transgenic miceRonald P Gladue, Susan H Cole, Marsha L Roach, et al.
FEBS Letters|May 27, 2008
HydF as a scaffold protein in [FeFe] hydrogenase H-cluster biosynthesisShawn E McGlynn, Eric M Shepard, Mark A Winslow, et al.
Dalton Transactions (Cambridge, England : 2003)|July 3, 2018
Compositional and structural insights into the nature of the H-cluster precursor on HydFAnna G Scott, Robert K Szilagyi, David W Mulder, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|August 1, 1995
CP-123,369: a potent, orally active immunosuppressive agentK Koch, D C Hanson, M F Newborg, et al.
Plos One|August 23, 2011
Implicating calpain in tau-mediated toxicity in vivoJames B Reinecke, Sarah L DeVos, James P McGrath, et al.
Pageof 31

Showing results (251-260 of 310) with videos related to

Sort By:
Pageof 31
Journal of the American Chemical Society|December 29, 2020
Active-Site Controlled, Jahn-Teller Enabled Regioselectivity in Reductive S-C Bond Cleavage of <i>S</i>-Adenosylmethionine in Radical SAM EnzymesStella Impano, Hao Yang, Richard J Jodts, et al.
The Journal of Biological Chemistry|August 5, 1991
p185HER2 signal transduction in breast cancer cellsG K Scott, J M Dodson, P A Montgomery, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 1992
Humanization of an anti-p185HER2 antibody for human cancer therapyP Carter, L Presta, C M Gorman, et al.
Angewandte Chemie (International Ed. in English)|March 23, 2022
[FeFe]-Hydrogenase: Defined Lysate-Free Maturation Reveals a Key Role for Lipoyl-H-Protein in DTMA Ligand BiosynthesisAdrien Pagnier, Batuhan Balci, Eric M Shepard, et al.
Journal of Medicinal Chemistry|April 14, 1995
The C-32 triacetyl-L-rhamnose derivative of ascomycin: a potent, orally active macrolactone immunosuppressantK Koch, M F Newborg, D C Hanson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2006
The human specific CCR1 antagonist CP-481,715 inhibits cell infiltration and inflammatory responses in human CCR1 transgenic miceRonald P Gladue, Susan H Cole, Marsha L Roach, et al.
FEBS Letters|May 27, 2008
HydF as a scaffold protein in [FeFe] hydrogenase H-cluster biosynthesisShawn E McGlynn, Eric M Shepard, Mark A Winslow, et al.
Dalton Transactions (Cambridge, England : 2003)|July 3, 2018
Compositional and structural insights into the nature of the H-cluster precursor on HydFAnna G Scott, Robert K Szilagyi, David W Mulder, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|August 1, 1995
CP-123,369: a potent, orally active immunosuppressive agentK Koch, D C Hanson, M F Newborg, et al.
Plos One|August 23, 2011
Implicating calpain in tau-mediated toxicity in vivoJames B Reinecke, Sarah L DeVos, James P McGrath, et al.
Pageof 31